Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3032% below fair value
$59.56−1.79 (-2.92%)
Close on Nov 18, 2026Market cap $121.75BP/E 13.2Yield 4.18%
Bristol Myers Squibb pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bristol Myers Squibb's pe ratio was 13.9× on Nov 11, 2026, against 16.6× a year earlier. Over the last 5 years it ranged from 11.4× to 73.7×, with a median of 18.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.9× | −4.4 |
| 2025 | Dec 31, 2025 | 18.2× | +6.8 |
| 2024 | Apr 30, 2024 | 11.4× | −1.6 |
| 2023 | Dec 29, 2023 | 13.0× | −10.4 |
| 2022 | Dec 30, 2022 | 23.4× | −49.0 |
| 2020 | Jul 31, 2020 | 72.4× | +53.8 |
| 2019 | Dec 31, 2019 | 18.6× | −40.5 |
| 2018 | Dec 31, 2018 | 59.1× | +34.9 |
| 2017 | Dec 29, 2017 | 24.1× | −5.1 |
| 2016 | Dec 30, 2016 | 29.2× | −35.7 |
| 2015 | Dec 31, 2015 | 64.9× | +28.7 |
| 2014 | Dec 31, 2014 | 36.2× | +4.4 |
| 2013 | Dec 31, 2013 | 31.8× | +1.9 |
| 2012 | Dec 31, 2012 | 29.9× | +11.6 |
| 2011 | Dec 30, 2011 | 18.3× | – |
See a number that looks wrong?